Steigerwald Gordon & Koch’s BioNTech BNTX Stock Holding History

Steigerwald Gordon & Koch’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-37	Closed	-$3.52K	–	793
2025 Q4	$3.52K	Buy	+37	New	+$3.73K	﹤0.01%	734

Other funds holding BNTX

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Steigerwald Gordon & Koch's BNTX Position: Q1 2026 in Review

Steigerwald Gordon & Koch sold out of BioNTech (BNTX) in Q1 2026, closing a stake of 37 shares — an estimated $3.52K sold.

Steigerwald Gordon & Koch first reported a position in BNTX in Q4 2025 and held it in 1 quarter. The position peaked at $3.52K in Q4 2025. 272 funds tracked by Wall St. Rank hold BNTX as of Q1 2026.

Steigerwald Gordon & Koch reported no remaining BioNTech position as of Q1 2026 after selling out during the quarter.
Steigerwald Gordon & Koch sold 37 BioNTech shares in Q1 2026, an estimated $3.52K.
Steigerwald Gordon & Koch first reported a position in BioNTech in Q4 2025 and held it in 1 quarter.
Steigerwald Gordon & Koch's BioNTech position peaked at $3.52K in Q4 2025.
272 funds tracked by Wall St. Rank held BioNTech as of Q1 2026.

Based on Steigerwald Gordon & Koch's 13F filing for Q1 2026, filed 28 Apr 2026.